These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
448 related items for PubMed ID: 15363959
1. Antagonism at metabotropic glutamate 5 receptors inhibits nicotine- and cocaine-taking behaviours and prevents nicotine-triggered relapse to nicotine-seeking. Tessari M, Pilla M, Andreoli M, Hutcheson DM, Heidbreder CA. Eur J Pharmacol; 2004 Sep 19; 499(1-2):121-33. PubMed ID: 15363959 [Abstract] [Full Text] [Related]
10. Metabotropic glutamate 5 receptor blockade may attenuate cocaine self-administration by decreasing brain reward function in rats. Kenny PJ, Boutrel B, Gasparini F, Koob GF, Markou A. Psychopharmacology (Berl); 2005 Apr 19; 179(1):247-54. PubMed ID: 15602687 [Abstract] [Full Text] [Related]
11. Effect of the mGluR5 antagonist 6-methyl-2-(phenylethynyl)pyridine (MPEP) on the acute locomotor stimulant properties of cocaine, D-amphetamine, and the dopamine reuptake inhibitor GBR12909 in mice. Mcgeehan AJ, Janak PH, Olive MF. Psychopharmacology (Berl); 2004 Jul 19; 174(2):266-73. PubMed ID: 14726993 [Abstract] [Full Text] [Related]
12. The effects of the mGluR5 receptor antagonist 6-methyl-2-(phenylethynyl)-pyridine (MPEP) on behavioural responses to nicotine. Tronci V, Vronskaya S, Montgomery N, Mura D, Balfour DJ. Psychopharmacology (Berl); 2010 Jul 19; 211(1):33-42. PubMed ID: 20422403 [Abstract] [Full Text] [Related]
13. A novel mGluR5 antagonist, MFZ 10-7, inhibits cocaine-taking and cocaine-seeking behavior in rats. Keck TM, Zou MF, Bi GH, Zhang HY, Wang XF, Yang HJ, Srivastava R, Gardner EL, Xi ZX, Newman AH. Addict Biol; 2014 Mar 19; 19(2):195-209. PubMed ID: 24001208 [Abstract] [Full Text] [Related]
14. Anxiolytic-like effects of the prototypical metabotropic glutamate receptor 5 antagonist 2-methyl-6-(phenylethynyl)pyridine in rodents. Spooren WP, Vassout A, Neijt HC, Kuhn R, Gasparini F, Roux S, Porsolt RD, Gentsch C. J Pharmacol Exp Ther; 2000 Dec 19; 295(3):1267-75. PubMed ID: 11082464 [Abstract] [Full Text] [Related]
15. Metabotropic glutamate receptor 5 antagonist 2-methyl-6-(phenylethynyl)pyridine (MPEP) microinfusions into the nucleus accumbens shell or ventral tegmental area attenuate the reinforcing effects of nicotine in rats. D'Souza MS, Markou A. Neuropharmacology; 2011 Dec 19; 61(8):1399-405. PubMed ID: 21896278 [Abstract] [Full Text] [Related]
16. Antiaggressive effects of MPEP, a selective antagonist of mGlu5 receptors, in agonistic interactions between male mice. Navarro JF, Postigo D, Martín M, Burón E. Eur J Pharmacol; 2006 Dec 03; 551(1-3):67-70. PubMed ID: 17026995 [Abstract] [Full Text] [Related]
17. Cocaine self-administration, extinction training and drug-induced relapse change metabotropic glutamate mGlu5 receptors expression: Evidence from radioligand binding and immunohistochemistry assays. Pomierny-Chamiolo L, Miszkiel J, Frankowska M, Bystrowska B, Filip M. Brain Res; 2017 Jan 15; 1655():66-76. PubMed ID: 27871824 [Abstract] [Full Text] [Related]
18. Effects of group I metabotropic glutamate receptor antagonists on the behavioral sensitization to motor effects of cocaine in rats. Dravolina OA, Danysz W, Bespalov AY. Psychopharmacology (Berl); 2006 Sep 15; 187(4):397-404. PubMed ID: 16896963 [Abstract] [Full Text] [Related]